Evidence map›Paper›PMID 30355627›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2018

Enhanced CRFR1-Dependent Regulation of a Ventral Tegmental Area to Prelimbic Cortex Projection Establishes Susceptibility to Stress-Induced Cocaine Seeking.

Oliver Vranjkovic, Erik C Van Newenhizen, Michael E Nordness, Jordan M Blacktop, Luke A Urbanik, Jacob C Mathy, Jayme R McReynolds, Anna M Miller, Elizabeth M Doncheck, Tyler M Kloehn and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. PVNAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Oliver VranjkovicDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Erik C Van NewenhizenDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.ORCID 0000-0001-9148-9056
Michael E NordnessDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Jordan M BlacktopDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.ORCID 0000-0001-8253-4302
Luke A UrbanikDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Jacob C MathyDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Jayme R McReynoldsDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Anna M MillerDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Elizabeth M DoncheckDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Tyler M KloehnDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Gwen S StinnettMolecular and Behavioral Neuroscience Institute, Neuroscience Graduate Program, and Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.ORCID 0000-0001-7156-7205
Clayton H GerndtDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Kyle D KetchesinMolecular and Behavioral Neuroscience Institute, Neuroscience Graduate Program, and Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
David A BakerDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and.
Audrey F SeasholtzMolecular and Behavioral Neuroscience Institute, Neuroscience Graduate Program, and Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
John R MantschDepartment of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53233 and john.mantsch@marquette.edu.ORCID 0000-0003-0099-1599
Marquette University · USUniversity of Michigan · US

Funding

Stress response and HPA regulation in cocaine addictionR01DA015758 · NIDA · MARQUETTE UNIVERSITY · PI MANTSCH, JOHN R. · 2002 to 2014
$2.8M
Sex differences in stress-potentiated cocaine seeking and the underlying mechanismsR01DA038663 · NIDA · MARQUETTE UNIVERSITY · PI HILLARD, CECILIA J, MANTSCH, JOHN R. · 2014 to 2018
$2.5M
NIDA NIH HHS R01 DA015758NIDA NIH HHS R01 DA038663
6 · The paper itself

Abstract

The ability of stress to trigger cocaine seeking in humans and rodents is variable and is determined by the amount and pattern of prior drug use. This study examined the role of a corticotropin releasing factor (CRF)-regulated dopaminergic projection from the ventral tegmental area (VTA) to the prelimbic cortex in shock-induced cocaine seeking and its recruitment under self-administration conditions that establish relapse vulnerability. Male rats with a history of daily long-access (LgA; 14 × 6 h/d) but not short-access (ShA; 14 × 2 h/d) self-administration showed robust shock-induced cocaine seeking. This was associated with a heightened shock-induced prelimbic cortex Fos response and activation of cholera toxin b retro-labeled VTA neurons that project to the prelimbic cortex. Chemogenetic inhibition of this pathway using a dual virus intersectional hM4Di DREADD (designer receptor exclusively activated by designer drug) based approach prevented shock-induced cocaine seeking. Both shock-induced reinstatement and the prelimbic cortex Fos response were prevented by bilateral intra-VTA injections of the CRF receptor 1 (CRFR1) antagonist, antalarmin. Moreover, pharmacological disconnection of the CRF-regulated dopaminergic projection to the prelimbic cortex by injection of antalarmin into the VTA in one hemisphere and the D1 receptor antagonist, SCH23390, into the prelimbic cortex of the contralateral hemisphere prevented shock-induced cocaine seeking. Finally, LgA, but not ShA, cocaine self-administration resulted in increased VTA CRFR1 mRNA levels as measured using

Indexed as

AnimalsCocaineConditioning, OperantCRF Receptor, Type 1Drug-Seeking BehaviorMaleNeural PathwaysPrefrontal CortexRatsRats, Sprague-DawleyReceptors, Corticotropin-Releasing HormoneSelf AdministrationStress, PsychologicalVentral Tegmental AreaCocaineCRF Receptor, Type 1Receptors, Corticotropin-Releasing HormonecocaineCRFdopamineprefrontalreinstatementstress

Identifiers

PMID30355627
PMCPMC6290294
OpenAlexW2898122683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.